Government Relations Committee

Chair

Chair: Lyndon Box MD, FSCAI (2019–2021)
Co-Chair: Joaquin E. Cigarroa, MD, FSCAI (2012–2021)
Board Liaison: Peter L. Duffy, MD, MMM, FSCAI
Quality Initiative Liaison: Faisal Latif, MD, FSCAI
Congenital Heart Disease Liaison: Sergio Bartakian, MD, FSCAI
Structural Heart Disease Liaison: Andrew Goldsweig, MD, RPVI, FSCAI
Vascular Heart Disease Liaison: Subhash Banerjee, MD, FSCAI
Staff Liaison: Curtis Rooney (crooney@scai.org)

Mission

To educate our members, ourselves, and key stakeholders (legislators and their staffs, government agencies, patients and the general public) about policies and positions that directly and indirectly affect all aspects of interventional cardiology and to advocate for those positions as directed by the Executive Committee of the Society for Cardiovascular Angiography and Interventions.

Goals

• Evaluate proposed legislation to understand its impact on interventional cardiologists and our patients.
• Ongoing outreach to federal agencies (evaluate and develop comment letters in response to proposed FDA, CMS, NIH, AHRQ federal regulations, getting to know agencies/outreach to federal agencies, assess existing relationships with agencies).
• Support select new interventional cardiology technologies by advocating for coverage and reimbursement of those technologies, when appropriate to support patient-centered decision making.
• Engage in federal and state-level legislative and regulatory proposals to positively influence the outcome.
• Identifying members who have strong contacts with key members of Congress.

Voting Members